BACKGROUND INFORMATION ON THE PROCEDURE 
1. 
Submission of the dossier 
The  company  Boehringer  Mannheim  GmbH.  submitted  on  10  October  1995  an  application  for 
Marketing Authorisation to the European Agency for the Evaluation of Medicinal Products (EMEA) 
for NeoRecormon, in accordance with the centralised procedure falling within the scope of Part A of 
the Annex to Council Regulation No (EEC) 2309/93 of 22 July 1993. 
The Rapporteur and Co-Rapporteur appointed by the CPMP were: 
Rapporteur: 
A.G. Hildebrandt 
Co-Rapporteur: 
J.H. Trouvin 
Licensing status: 
The product was not licensed in any country at the time of submission of the application. 
2. 
Steps taken for the assessment of the product 
• 
• 
• 
• 
• 
• 
• 
• 
• 
The procedure started on 1 November 1995. 
The  Rapporteur’s  initial  assessment  report  was  circulated  to  all  CPMP  Members  on 
15  February  1996.  The  Co-Rapporteur’s  assessment  report  was  circulated  to  all  CPMP 
Members on 15 February 1996. 
The  CPMP 
15 March 1996 and the clock was stopped. 
consolidated 
list 
of 
questions  was 
sent 
to 
the 
company 
on  
The  company  submitted  the  responses  to  the  CPMP  consolidated  list  of  questions  on 
1 August 1996 and the clock was restarted. 
The  Rapporteur's  and  Co-Rapporteur’s  assessment  reports  to  the  company’s  responses  was 
circulated to all CPMP members on 15 September 1996. 
A  hearing  with  the  company  took  place  on  15  October  1996,  to  address  the  final  outstanding 
issues. 
Amendments  were  made  accordingly  to  the  Summary  of  Product  Characteristics  and  Package 
Leaflet texts. 
In the light of the overall data submitted and the scientific discussion within the Committee, the 
CPMP  issued  a  positive  opinion  for  granting  a  marketing  authorisation  for  the  14  different 
presentations of NeoRecormon on 16 October 1996. 
The  CPMP  Opinions  were  forwarded  in  all  official  languages  of  the  EU  to  the  European 
Commission, which adopted the corresponding Decisions on 16 July 1997. 
1/1 
EMEA 2004 
 
 
 
 
 
 
 
 
 
 
